The U.S. Food and Drug Administration (FDA) is alerting people who use Philips Respironics ventilators, BiPAP, and CPAP machines and their health care providers that Philips Respironics has recalled certain devices (see table below) due to potential health risks. The polyester-based
Robotic surgical equipment, now solely made in the United States by Intuitive surgical Inc. of Sunnyvale, Calif., has been a topic of controversy since its U.S Food and Drug Administration approval in 2000. Recently at Beth Israel Deaconess Medical Center, seven nurses and doctors
Within the last year, Massachusetts acute-care hospitals reported over 750 serious medical errors and patient injuries. This number is a 70 percent jump from previous years, causing concern for Hospital executives, as well as the patients and their families who were harmed by these errors.
Life-threatening infections have become all too common in hospitals, particularly after surgeries. Catastrophic infection can occur in such settings if proper precautions by hospitals and medical personnel are not taken. Recent research suggests that there is reason to be concerned about 3M’s Bair Hugger Patient
On October 10, an agreement with the Department of Public Health’s Board of Registration in Pharmacy was signed, stating that Ameridose and its distribution partner, Alanaus Pharmaceuticals, are voluntarily shutting down operations until October 22 to allow inspectors the access needed to conduct an investigation.
Within a few months after the Stryker hip replacement system was recalled, plaintiffs’ lawyers have filed the first lawsuits against the hip implants’ manufacturer, Howmedica Osteonics Corp. According to plaintiffs’ attorneys, the alleged problems with the Stryker Rejuvenate Modular and ABG II involve the
President Obama has presented Marietta S Robinson as his nominee as a commissioner with the U.S. Consumer Product Safety Commission (CPSC). If confirmed, Ms. Robinson would be in place as the fifth commissioner now leading the government agency. The CPSC oversees the quality and
Novartis Consumer Health, Inc. has announced a voluntary recall, along with a temporary shutdown of its Nebraska production facility. The recall relates to the over-the-counter drugs Bufferin, Excedrin, Gas-X Prevention, and NoDoz and results from reports of chipped and broken pills, as well as "inconsistent
